Independent Research
TWST Analysis
4 pieces of research on Twist Bioscience Corporation. We find the signal management buried in the earnings call.
3signal analyses
1news briefs
latest: Sep 23, 2026
Signal Analysis (3)
Analysis
Twist Bioscience Raises Capital as Insiders Sell $77M
Twist Bioscience filed equity offering prospectuses in August while its executives simultaneously sold $76.84 million in shares with zero purchases — and the st…
Read analysis →Analysis
Twist CEO Sells $56M at Rally Peak, Stock Tops Targets
Twist Bioscience CEO Emily Leproust sold $56.33M on September 17 at the peak of a 33% rally tied to the Lilly TuneLab partnership, cashing out deeply in-the-mon…
Read analysis →Analysis
Twist Bioscience Insiders Sell $25M Into AI-Driven Rally
Twist Bioscience shares trade roughly 29% above analyst consensus on a reported guidance hike and Anthropic-linked AI announcement, yet insiders net-sold $24.97…
Read analysis →